Description of telehealth and e-medicine

Create a compelling presentation to convince the CEO of an organization of the benefits of e-medicine and telehealth. Include the following:
Description of telehealth and e-medicine
Explanation of the available technologies
Telehealth and e-medicine program recommendation
Statistical research to support your recommendation
How data tracking is improved through telehealth and e-medicine
Format your presentation as one of the following:
7- to 10-slide presentation
7- to 10-minute oral presentation
450-word executive summary
1-page infographic
Another format approved by your instructor
Include detailed speaker notes and at least three, current, APA-formatted references.

What has led to the increase in MRSA transmission in the community (MIAMI)? What are some of the challenges in addressing this problem in the community? How is it often identified and how can it be passed in communities?

1. How does your state (Florida, USA) differ from other states related to vaccination requirements? Have there been any recent changes in vaccination requirements? How do students feel about the possibility of including the HPV vaccine as a requirement for school? What are the pros and cons?
2. What has led to the increase in MRSA transmission in the community (MIAMI)? What are some of the challenges in addressing this problem in the community? How is it often identified and how can it be passed in communities?
3. Based on what you saw in the YouTube presentation
https://www.youtube.com/watch?v=NQ1cwNibHz0,
Do you think that PrEP/Truvada it is effective in preventing HIV/AIDS?
Present your assignment in an APA format word document Arial 12 font attached to the forum in the discussion board tittle “week 5 discussion questions”. Assignment must contained at least two evidence based references no older than 5 years. Minimum of 300 words.

what antifungal medication should this patient be prescribed?

Week 5
Discussion question worth 5 points
Discussion question due by Sunday, 11:59 pm.
Following Case Study Question: As an NP student, needs to determine the medications for Tinea Pedis.
RX format: Medication, SIG: Instructions (Route, frequency, location, duration), Dispense #, Refills, ?
According to the ACC/AHA Guidelines, what antifungal medication should this patient be prescribed? Write her complete prescriptions using the prescription writing format and SOAP (subjective, objective, assesment, plan) format.
Please include patient education regarding the selected medication therapy. Please choose a medication to treat tinea pedis that would not exacerbate other patient’s symptoms. You may order labs for baseline before starting the therapy and specify which labs.
Next to the chosen medication therapy, please choose references to support your treatment choice of medication or lab for baseline and follow up of therapy ordered. Specify when to refer the patient after therapy and why ?
WEEK 5: DISCUSSION QUESTION IN DISCUSSION BOARD
DERMATOLOGY CASE STUDY
ACC/AHA Guidelines
Chief complaint: “ I have scaly crust in sole of feet and moist white crusts between my toes since I started using boots warm weather” for past 2 weeks.
HPI: E.D a 45-year-old hispanic female presents to the clinic for complaint of itching in feet and scaly curst in sole of feet and moist white crusts between toes. She developed a red, itchy rash consistent with hypersensitivity reaction. She also indicates that she has noticed that her symptoms are worsening for past 2 weeks and it started after she started to use boots in warm weather. She has symptoms of red, itching rash consistent with a hypersensitivity reaction and tinea pedis. She wore about 2 weeks ago her mother’s shoes without socks and her mother has history of Tinea Pedis.
She has tried lotrimin AF cream for itching and it did not help relief her symptoms. She has not tried other remedies.
Denies associated symptoms of fever, chills, pain or any other symptoms.
PMH:
Diabetes Mellitus, type 2. Peripheral Vascular disease. Varicose Veins.
Surgeries: None
Allergies: Penicillin
Vaccination History:
She receives an annual flu shot. Last flu shot was this year
Social history:
High school graduate, married and no children. He drinks one 4-ounce glass of red wine daily. He is a former smoker that stopped 3 years ago.
Family history:
Both parents are alive. Father has history of DM type 2, Tinea Pedis.
mother alive and has history of atopic dermatitis, tinea corporis and tinea pedis.
ROS:
Constitutional: Negative for fever. Negative for chills.
Respiratory: No Shortness of breath. No Orthopnea
Cardiovascular: + 1 pitting leg edema. + Varicose veins.
Skin: + rash crusted white in feet and inter-digit in feet.
Psychiatric: No anxiety. No depression.
Physical examination:
Vital Signs
Height: 5 feet 5 inches Weight: 140 pounds BMI: 31 obesity, BP 130/70 T 98.0 po P 88 R 22, non-labored
HEENT: Normocephalic/Atraumatic, Bilateral cataracts; PERRL, EOMI; No teeth loss seen. Gums no redness.
NECK: Neck supple, no palpable masses, no lymphadenopathy, no thyroid enlargement.
LUNGS: No Crackles. Lungs clear bilaterally. Equal breath sounds. Symmetrical respiration. No respiratory distress.
HEART: Normal S1 with S2 during expiration. Pulses are 2+ in upper extremities. 1+ pitting edema ankle bilaterally.
ABDOMEN: No abdominal distention. Nontender. Bowel sounds + x 4 quadrants. No organomegaly. Normal contour; No palpable masses.
GENITOURINARY: No CVA tenderness bilaterally. GU exam deferred.
MUSCULOSKELETAL: Slow gait but steady. No Kyphosis.
SKIN: +Dryness, No open lesions. +Dry crusts in sole of feet. + moist crust in between toes.
PSYCH: Normal affect. Cooperative.
Labs:: Hgb 13.2, Hct 38%, K+ 4.0, Na+137, Cholesterol 225, Triglycerides 187, HDL 37, LDL 190, TSH 3.7, glucose 98
A:
Primary Diagnosis: Tinea Pedis
Secondary Diagnoses:
Atopic Dermatitis
Xerosis
Pruritus
Differential Diagnosis:
Peripheral Vascular Disease (PVD) (173.9)
P:
Medications:
Tylenol 650 mg PO Q4 hours as needed for arthritis pain
Labs: CBC with diff to evaluate for infection and baseline lab. CMP, PT/INR to evaluate status of liver and kidneys.
Referrals: may refer based on effect of medication therapy given for 2 weeks.
Follow up: return to office in 2 weeks to evaluate her symptoms.
Additional lab results:
Fungal culture confirm that she has fungal infection.
Question: As an NP student, needs to determine the medications for Tinea Pedis.
According to the ACC/AHA Guidelines, what antifungal medication should this patient be prescribed? Write her complete prescriptions using the prescription writing format. Write her complete prescriptions using the prescription writing format and SOAP (subjective, objective, assesment, plan) format.
Next to the chosen medication therapy, please choose references to support your treatment choice of medication or lab for baseline and follow up of therapy ordered. Specify when to refer the patient after therapy and why ? Choose a medication to treat the patient’s condition of tinea pedis that would not exacerbate other patient’s symptoms. You may order labs for baseline before start of therapy and specify which labs.

Propose an initiative that will address this problem within the department of your chosen healthcare organization. What specific relevant quality standard will this quality initiative address?

Milestone 2 Health Paper
You will also implement your performance improvement initiative and discuss what success of the performance improvement plan will look like after implementation. As this is a scholarly initiative, this assignment must adhere to all APA requirements and formatting, and include peer-reviewed and evidence-based sources to support any and all claims. As you develop this final part of the assignment, consider the following prompts to formulate your paper. TOPIC is Medication Errors
Reference part 1 of this paper to assist:
You will write paper on the below parts III and IV. Be sure to see reference paper for parts I and II.
III. Performance Improvement Initiative
A. Propose an initiative that will address this problem within the department of your chosen healthcare organization. What specific relevant quality standard will this quality initiative address?
B. Discuss the data determinants of success, as related to this initiative. In other words, what type of data will be indicative of a quality outcome?
IV. Implementation of the Plan in the Organization
A. What interdepartmental communication channels will be used for plan implementation?
B. What manner of data interpretation will be used to communicate the findings within the organization?
C. If this initiative was implemented, what do you believe would be the hypothetical effect(s) on patient care outcomes? How will health information systems support those improvements in patient care?
D. What do you think the hypothetical effect of the quality or performance initiative will be on the culture of safety within the organization?
Guidelines for Submission: Submit assignment as a Word document with double spacing, 12-point Times New Roman font, and one-inch margins. Two pages long and the reference page
Milestone 1
Medication Errors.docx
Running Head: PATIENT MEDICATION ERRORS
PATIENT MEDICATION ERRORS
Patient Medication Errors
Milestone 1
Introduction
In any medical facility, the medication of patients is among the most important things. Making sure that patients get the right medication is essential as wrong medication can have very adverse long-term effects on the patients’ health. However, there are times when the errors occur during the process of administering medication to the patients. When providing health care services to the patients, their safety should be a top priority for any health care facility management team. However, in the past, there have been some errors which have been occurring during the provision of the healthcare services.
Organizational Problem
Medication Errors and the Costs
In the United States and other countries, medication errors are a very big concern. It is a challenge facing a lot of medical facilities all over the world. Dealing with it is very important as it helps to save the patients as well as reducing the cost coming up due to the errors committed during the process of administering medication.
Barker, Flynn, Pepper, Bates & Mikeal, (2002), State that medication errors are common. Statistics show that the rate in hospitals and other skilled nursing facilities, the rate is almost 20%. This is way above the minimum harmful rate of about 7%.
Medication errors have been a major challenge all over the world. Many stakeholders in the healthcare sector have been collaborating to come up with means of reducing the risks of these errors during the provision of medical services to the patients. It is important to note that the cost of these errors is exceptionally high. According to Donaldson, Kelley, Dhingra-Kumar, Kieny, & Sheikh (2017), the cost of medication errors is over $40 billion. According to the same article, an estimated $3.5 billion is lost every year, which is aimed at treating hospitalized patients.
To continue improving the patients’ safety, there is the need to make sure that all stakeholders including the regulatory bodies are involved to minimize the cases of avoidable harm to the patients. Addressing the challenges is at the heart of the health ministers. Reducing the medication errors will not only be important in saving cost but also in reducing the cases of harm and deaths caused by the errors.
Organizational Challenges
Among the major organizational challenges being faced by medical facilities due to medication errors include budgeting. With the soaring global costs due to these errors, budgeting is a big challenge. Globally, the cost of these errors is about $42 billion according to Donaldson et al. (2017). Also, there are increased interdepartmental conflicts as the medication errors, and wrong decision-making by a single department in the health facility affects all other departments. Communication also becomes a very big challenge.
Evidence-Based Support
Data Supporting the Existence of the Problem
There is a lot of data suggesting the existence of the patient medication errors. For example, the data of the cost incurred by the stakeholders in the healthcare facilities worldwide. As Donaldson (2017) puts it, the medication errors cost organizations over 42 billion dollars every single year. Also, according to Wahr & Merry (2017), in the operating room, the risk of errors in medication is estimated to be 1 in every 20 people. Additionally, according to Leape and associates, there is about 56 percent of errors caused by prescription and 44 percent as a result of administration.
Addressing the Problem in the Past
Numerous stakeholders have come together to try solving the issue. World Health Organization formed partnerships with other stakeholders in the healthcare sector including the World Alliance for Patient Safety, to help reduce the errors. These have been working on coming up with global patient challenges. Also, they aim at making sure that the patients get clean and quality health care, which is safer. In collaboration with health ministers worldwide, these individuals work towards ensuring that the patients can get the best quality healthcare while maintaining high levels of patient safety (Donaldson, Kelley, Dhingra-Kumar, Kieny, & Sheikh, 2017).
Relevant Accreditation Standards, Safety Standards, Compliance Standards, and Quality Initiatives
The safety of patients is very important, and numerous standards have been put in place to ensure that the safety is promoted. For example, Failure Mode, Effect, and Criticality Analysis also referred to as FMECA, is a standard used to enhance patients’ safety (Montesi & Lechi, 2009). Regulations set by organizations such as Food and Drug Administration (FDA) are important and should be complied with during the administration of any medication to patients.
References
Barker, K. N., Flynn, E. A., Pepper, G. A., Bates, D. W., & Mikeal, R. L. (2002). Medication errors observed in 36 healthcare facilities. Archives of internal medicine, 162(16), 1897-1903.
Donaldson, L. J., Kelley, E. T., Dhingra-Kumar, N., Kieny, M. P., & Sheikh, A. (2017). Medication Without Harm: WHO’s Third Global Patient Safety Challenge. The Lancet, 389(10080), 1680-1681.
Montesi, G., & Lechi, A. (2009). Prevention of medication errors: detection and audit. British journal of clinical pharmacology, 67(6), 651-655.
Wahr, J. A., & Merry, A. F. (2017). Medication Errors in the Perioperative Setting. Current Anesthesiology Reports, 7(3), 320-329.

Theorists tend to view technological advances, like AI, machine learning, and robotics as a great benefit to future society or as a looming threat to the future of humanity

On-line Assignment #1

Please, complete the following assignment and submit your work as a thread to the discussion. Your written submission is due by midnight on Wednesday, January 31st. Your next step is to comment on 2 of your classmates’ posts before midnight on Sunday, February 4th.
This assignment comprises 5% of your final grade.
Please, watch one of the following videos and read one of the following articles. If you find the topic interesting, please read or watch more than one of the suggestions.
Answer ONE of the following prompts based on your reading, viewing, class discussion, and personal experiences. Your response should be approximately 500 words.

  1. Reflect on the concepts that you found most interesting this week, and suggest how these concepts will influence your future.
  2. Theorists tend to view technological advances, like AI, machine learning, and robotics as a great benefit to future society or as a looming threat to the future of humanity. Based on your learning, share your opinion about the benefits or threats of these technological advances. Use specific examples to support your response.
  3. Discuss some of the main ideas that you took away from the reading and video. How will your career choices be influenced by advances in AI.

Selection of readings:
The Future of Human Work is Imagination, Creativity, and Strategy (Harvard Business Review, January 2018)
https://hbr.org/2018/01/the-future-of-human-work-is-imagination-creativity-and-strategy
How to Prepare the Next Generation for Jobs in the AI Economy (Harvard Business Review, June 2017)
https://hbr.org/2017/06/how-to-prepare-the-next-generation-for-jobs-in-the-ai-economy
Selection of videos:
Machine Intelligence makes Human Morals more Important (TedTalk with Zeynep Tufekci)

The Future we are Building – and Boring (TEDTalk with Elon Musk)

How We will Earn Money in a Future without Jobs (TEDTalk with Martin Ford)
https://www.ted.com/talks/martin_ford_how_we_ll_earn_money_in_a_future_without_jobs
Can a Robot Pass a University Entrance Exam? (TEDTalk with Noriko Arai)
Can we Build AI without Losing Control over it? (TEDTalk with Sam Harris)

 

Restoration/Rejuvenation – Sleep, Rest, Relaxation

1
Please choose one of the following health conditions or responses to stress related issues, research it and report in detail in APA format using the paper template provide below. Cite peer reviewed reference sources from journals
and incorporate all resources used including internet websites.
 
Be certain to address the following separate areas of influence to health:
1) Restoration/Rejuvenation – Sleep, Rest, Relaxation
2) Nutrition – Food , Air, Hydration, Supplementation
3) Activity – Physical, Psychological, Social, Spiritual
4) Emotional Awareness – How they affect our health
Paper Template
Introduction:
The condition/issue, disease or illness you are examining/exploring. Why it is
a concern to the individual and/or society and why it merits examination.
Literature Review:
Review what others have found and reported on prior (authors, researchers, practitioners). Minimum of three peer reviewed journal articles from academic databases and/or other credible resources.
Finding:
What you have found related to topic from all sources. Will include personal experience, opinion and other findings from literature and research, possibly interviews or surveys.
Discussion:
What may be beneficial or necessary for individuals or society to do if they
have concerns in this particular or related areas of health. This may include
how modern Western approaches compare with ancient Eastern medicine
alternatives and how they vary or parallel in terms of diagnosis and treatment.
Summary and Conclusion:
To bring more focus on what you believe to be a beneficial approach to dealing with problem. May be a combination of Eastern and Western ways. Please do not hesitate to speculate and make recommendations, especially with regards
to lifestyle changes.
Reference:
Cite all reference materials in America Psychological Association (APA) style and give credit where it is due. The following are helpful web-sites for APA style:
http://www.apastyle.org/faqs.html
http://blog.apastyle.org/apastyle/2011/11/the-proper-use-of-et-al-in-apa-style.html

Describe the differences in primary, secondary, and tertiary prevention in public health.

Describe the differences in primary, secondary, and tertiary prevention in public health. Provide one example for each level of public health prevention. For each example provided, explain the relationship between the example provided and the level of prevention. Also discuss the benefits and the potential consequences at each level.
Support your statements with scholarly references and appropriate examples.

Identify one professional journal and one nursing or health care conference where you might present your project.

Dissemination of EBP and research, such as presenting results at a conference or writing an article for a journal, is an important part of professional practice.
Identify one professional journal and one nursing or health care conference where you might present your project.
Discuss why each of your choices is the best option for you to disseminate your new knowledge.

Name two potential barriers that may prevent your EBP change proposal

Sustaining change can be difficult, as there are many variables that can affect implementation
One critical component of EBP is to ensure that practice change is part of an organization’s culture so it will continue to impact outcomes over time.
Name two potential barriers that may prevent your EBP change proposal from continuing to obtain the same desired results 6 months to a year from now, and your strategies for overcoming these barriers.